With predictive modeling for biological processes coming into the front, the manufacture of drugs is becoming more sophisticated. Researchers are now experiencing wider access to molecular and clinical data, which is further categorizing the potential molecules that can be transformed into drugs to act on biological targets. R&D in the pharma space is majorly confined within the realms of laboratories, faced with the challenge of unavailability of information and inaccurate results. New-age researchers are, however, making collaborative efforts both internally and externally, consequently breaking silos that segregate internal functions and enriching their data networks and knowledge base. The sole objective of widespread collaboration is to enhance end-to-end integration among all linkages that keep stakeholders in loop regarding research of drugs, their development, commercialization and delivery.
In an ambitious bid to promote telemedicine, more solution providers are now considering the use of remote patient monitoring and diagnostics, disaster management and healthcare applications, along with drones. It may not be long when drones would carry life-saving drugs or defibrillators for patients in remote locations that are difficult for ambulances or doctors to reach. Moreover, neonatal intensive care units (NICUs) are becoming more patient-friendly and reliable; care givers and care receivers are made aware of the NICU complications and the medicines available in the inventories. The pharma industry is witnessing a swift adoption of next-generation sequencing (NGS) technology in its diagnostic functions. The collaboration of big data analytics and cloud computing is playing a pivotal role in all biotech and pharmaceutical innovations, making way for new branches of technology in the industry, such as Precision Medicine, Toxgnostic, Pharmacogenomics, and Pharmacoepidemiology. As a result, pharma companies are able to observe a future-ready approach to drug discovery, research and development. We present to you Pharma Tech Outlook’s “Top 10 Analytics Solution Providers - 2020” and “Top 10 Analytics Consulting/Services Companies - 2020.”